Latest Articles
Absci Announces First Participants Dosed in Phase 1/2a - GlobeNewswire
Absci Announces First Participants Dosed in Phase 1/2a GlobeNewswire
Published: Dec. 4, 2025, 1 p.m.
Bayer Aims To Broaden Mirena’s Use With Phase III Endometrial Hyperplasia Study - Citeline News & Insights
Bayer Aims To Broaden Mirena’s Use With Phase III Endometrial Hyperplasia Study Citeline News & Insights
Published: Dec. 4, 2025, 11:19 a.m.
Marquis Who's Who Honors Elham Neisani Samani, MD, for Excellence in Health Care - 24-7 Press Release
Marquis Who's Who Honors Elham Neisani Samani, MD, for Excellence in Health Care 24-7 Press Release
Published: Dec. 4, 2025, 8:36 a.m.
Scots woman demands change after 'losing organs' to 'cruel' disease - MSN
Scots woman demands change after 'losing organs' to 'cruel' disease MSN
Published: Dec. 4, 2025, 12:47 a.m.
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia - BioSpace
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia BioSpace
Published: Dec. 3, 2025, 2:11 p.m.
Post-Cesarean Surgical Scar Endometriosis: A Case Study and Clinical Insights from Somalia - Dove Medical Press
Post-Cesarean Surgical Scar Endometriosis: A Case Study and Clinical Insights from Somalia Dove Medical Press
Published: Dec. 3, 2025, 8:34 a.m.
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia - sharewise.com
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia sharewise.com
Published: Dec. 3, 2025, 5:04 a.m.
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia - Business Wire
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia Business Wire
Published: Dec. 2, 2025, 1:05 p.m.
Bayer (BAYRY) starts SUNFLOWER Phase III Mirena trial for nonatypical endometrial hyperplasia - Stock Titan
Bayer (BAYRY) starts SUNFLOWER Phase III Mirena trial for nonatypical endometrial hyperplasia Stock Titan
Published: Dec. 2, 2025, 1:05 p.m.
Amy Schumer says she lost 50lbs to 'survive' potentially fatal disease - LADbible
Amy Schumer says she lost 50lbs to 'survive' potentially fatal disease LADbible
Published: Dec. 2, 2025, 12:46 p.m.
Link copied to clipboard!